| Expression pattern: |
UP |
| Associated gene: |
HuR, CCND1 |
| Associated microRNA: |
miR‐646 |
| Biological function: |
promotes LSCC cell proliferation and tumor growth |
| Molecular mechanism: |
circ-CCND1 binds HuR to enhance CCND1 mRNA stability and sponges miR-646 to relieve repression on CCND1 3′-UTR, coordinately elevating CCND1 expression post-transcriptionally |
| Biological pathway or process: |
proliferation (promotes); cell cycle (promotes); ceRNA regulation (promotes); mRNA stability (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; Survival Analysis; Cohort Study; Transfection; Colony Formation Assay; Cell Cycle Assay; In Vivo Animal Model; Western Blot; RIP (RNA Immunoprecipitation); RNA Pull-Down; Luciferase Reporter Assay; Actinomycin D / DRB Stability Assay |
| Clinical significance: |
High circ-CCND1 is associated with aggressive clinical features and shorter overall survival in LSCC |
| Description: |
circ-CCND1 is up-regulated in LSCC and promotes proliferation and xenograft tumor growth. It elevates CCND1 expression post-transcriptionally by binding HuR to enhance CCND1 mRNA stability and by sponging miR-646 to relieve repression on CCND1 3′-UTR; high circ-CCND1 correlates with aggressive features and poorer overall survival. |
| Confidence score: |
0.8215 |